Abstract: A bathroom drying system, including a ceiling fan, including an outer cover to removably connect to at least a portion of a ceiling, a plurality of fan blades movably disposed within at least a portion of the outer cover to blow air and dry at least one of a shower and a bathtub, and a light connected to at least a portion of the outer cover to illuminate and emit at least one beam of light therefrom, a fan control device connected to the ceiling fan to control at least one operation of the plurality of fan blades, and a light control device connected to the light to control at least one operation of the light.

Abstract: A granular material manipulation device may include an upper handle and a lower handle. One or more upper arms may be coupled to the upper handle so that the upper arms may extend away from the upper handle. One or more lower arms may be coupled to the lower handle so that the lower arms may extend away from the lower handle. A positioning pivot may be configured to enable the device to be movable between a first and a second position. The lower arms may be positioned relatively closer to the upper arms in the first position, and the lower arms may be positioned relatively farther from the upper arms in the second position. Preferably, the device may be biased to the first position. A plate may be pivotally coupled to the first upper arm and/or to the second upper arm via one or more plate pivots.

Abstract: A peritoneum removal assembly for removing the peritoneum from a cut of raw meat includes a rod that has a pair of polygonal sections that can be engaged by a chuck on a power drill thereby facilitating the rod to be rotated about a lengthwise axis of the rod. A slot is integrated into the rod such that a peritoneum on a cut of raw meat can be extended through the slot. The slot extends toward the polygonal section such that the slot rotates about the lengthwise axis of the rod. In this way the slot facilitates the peritoneum to wrap around the rod when the power drill is turned on for removing the peritoneum from the cut of raw meat.

Abstract: A peritoneum removal assembly for removing the peritoneum from a cut of raw meat includes a rod that has a pair of polygonal sections that can be engaged by a chuck on a power drill thereby facilitating the rod to be rotated about a lengthwise axis of the rod. A slot is integrated into the rod such that a peritoneum on a cut of raw meat can be extended through the slot. The slot extends toward the polygonal section such that the slot rotates about the lengthwise axis of the rod. In this way the slot facilitates the peritoneum to wrap around the rod when the power drill is turned on for removing the peritoneum from the cut of raw meat.

Abstract: A pan for separating granular material may include a bottom wall and a sidewall. The sidewall may have an upper perimeter and a lower perimeter, and the lower perimeter may be coupled to the bottom wall so that the bottom wall and sidewall are watertight or otherwise configured to hold a volume of water. Preferably, the upper perimeter may be larger in dimension than the lower perimeter. A baffle plate may be coupled to the sidewall so that the baffle plate may be positioned between the upper perimeter and the lower perimeter. The baffle plate may have a proximal surface and an opposing distal surface, and portions of the proximal surface may contact the sidewall. A pocket may be formed between the bottom wall, the first baffle plate, and a portion of the sidewall that is between the bottom wall and sidewall.

Abstract: A fiber optic cassette includes structural features that maintain segregation between incoming and outgoing optical fibers. A dividing wall and a set of splice holders within the cassette together define two separate chambers within the cassette. Cable entry openings on the rear end of the cassette are configured to receive fiber optic cables into the rear chamber defined by the dividing wall and the splice holders. The front chamber is configured to hold patching fibers that interface with fiber optic adapters on the front of the cassette. The patching fibers and incoming optical fibers can be spliced as needed, and the splices held in place by the splice holders. This arrangement ensures that the incoming optical fibers from the fiber optic cable and the patching fibers remain segregated, such that the splice points are the only points of contact between the two sets of fibers.

Abstract: A fiber optic cassette includes structural features that maintain segregation between incoming and outgoing optical fibers. A dividing wall and a set of splice holders within the cassette together define two separate chambers within the cassette. Cable entry openings on the rear end of the cassette are configured to receive fiber optic cables into the rear chamber defined by the dividing wall and the splice holders. The front chamber is configured to hold patching fibers that interface with fiber optic adapters on the front of the cassette. The patching fibers and incoming optical fibers can be spliced as needed, and the splices held in place by the splice holders. This arrangement ensures that the incoming optical fibers from the fiber optic cable and the patching fibers remain segregated, such that the splice points are the only points of contact between the two sets of fibers.

Abstract: Devices that generate electrical energy from a flow of pressurized gas and methods of use thereof. While in no way limited thereto, exemplary device embodiments are ideally suited for powering electrical energy consuming devices wherever pressurized gas (e.g., air) is available but electrical primary power is not. This includes, for example, control and monitoring equipment, especially wireless devices, in industrial settings and in remote settings such as pipelines.

Abstract: The present invention relates to methods of identifying whether a candidate compound is a modulator of a G protein-coupled receptor (GPCR). In preferred embodiments, the GPCR is human. In other preferred embodiments, the GPCR is coupled to Gi and lowers the level of intracellular cAMP. In other preferred embodiments, the GPCR is expressed endogenously by adipocytes. In further preferred embodiments, the GPCR inhibits intracellular lipolysis. In other further preferred embodiments, the GPCR is a nicotinic acid receptor. The present invention also relates to methods of using a modulator of said GPCR. Preferred modulator is agonist. Agonists of the invention are useful as therapeutic agents for the prevention or treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, stroke, insulin resistance, and type 2 diabetes.

Abstract: A system is provided for monitoring at least one data bus of an aircraft. The system includes an aircraft adapted to control the operation of stores of a second predetermined type (e.g., Harpoon Block I missiles). However, the aircraft is also capable of carrying a store of a first predetermined type (e.g., Harpoon Block II missiles), and capable of communicating with the store across a communication bus (e.g., MK-82 Digital Data Bus). The system also includes a bus monitor assembly capable of capturing data communications transferred across the communication bus between the aircraft and the store, the data communications being captured from the communication bus. The bus monitor assembly is also capable of preparing the data communications, and monitoring the communication bus across which the data communications are transferred, the communication bus being monitored based upon the prepared data communications.

Abstract: A protective coating for a roof membrane of the type having plasticizers. The protective or barrier seal coating is applied the exposed surface of the polymeric roofing material, where it prevents and/or retards plasticizer migration to the surface of the membrane where they are subsequently removed. By preventing or retarding loss of plasticizers from the roof membrane, the concentration gradient of plasticizers throughout the membrane can be maintained and the life of the membrane can be extended. The protective or barrier seal coating may be further coated with conventional coatings such as elastomeric acrylics. Methods of applying the protective or barrier seal coating are disclosed.

Abstract: Arc chambers for discharge lamps, such as ceramic metal halide lamps, have ends, where the electrodes for the arc chambers are introduced, that are configured such that, when the arc chambers are arranged vertically, the metal halide additives in the arc chambers will accumulate substantially only on the inner surfaces of the ends, which can have closure walls that are thicker than the thickness of the walls of the body portions of the arc chambers. The ends can be further configured such that the metal halides are deposited substantially uniformly in a thin layer over the ends of the arc chambers. The ends can also be configured in a manner that no sharp edges are provided at the ends of the arc chambers so that corrosive effects to the arc chamber resulting from localized temperature variations are minimized.

Abstract: A discharge lamp including an arc tube having an elongated body enclosing a discharge chamber. The discharge chamber receiving first and second electrodes therein for forming an arc discharge in the discharge chamber. The lamp also including an outer envelope having an envelope cavity therein. A support member is received in the envelope cavity for supporting the arc tube. A containment member extends from the support member and is received around at least a portion of the elongated body of the arc tube. Additionally, a method of manufacturing a discharge lamp is disclosed.

Abstract: The present invention relates to methods of identifying whether a candidate compound is a modulator of a G protein-coupled receptor (GPCR). In preferred embodiments, the GPCR is human. In other preferred embodiments, the GPCR is coupled to Gi and lowers the level of intracellular cAMP. In other preferred embodiments, the GPCR is expressed endogenously by adipocytes. In further preferred embodiments, the GPCR inhibits intracellular lipolysis. In other further preferred embodiments, the GPCR is a nicotinic acid receptor. The present invention also relates to methods of using a modulator of said GPCR. Preferred modulator is agonist. Agonists of the invention are useful as therapeutic agents for the prevention or treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, stroke, insulin resistance, and type 2 diabetes.

Abstract: The present invention relates to a method for identifying a metabolic stabilizing compound, comprising: a) contacting a candidate compound with GPR35, and b) determining whether GPR35 functionality is increased, wherein an increase in GPR35 functionality is indicative of the candidate compound being a metabolic stabilizing compound. The invention further relates to a method for treating or preventing a metabolic-related disorder, comprising administering to an individual in need thereof an effective amount of a GPR35 modulator.

Abstract: The present invention concerns combination of an amount of a GPR119 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-1 level in a subject over that provided by the amount of the GPR119 agonist or the amount of the DPP-IV inhibitor alone and the use of such a combination for treating or preventing diabetes and conditions related thereto or conditions ameliorated by increasing a blood GLP-1 level. The present invention also relates to the use of a G protein-coupled receptor to screen for GLP-1 secretagogues.

Abstract: The present invention concerns combination of an amount of a GPR119 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-1 level in a subject over that provided by the amount of the GPR119 agonist or the amount of the DPP-IV inhibitor alone and the use of such a combination for treating or preventing diabetes and conditions related thereto or conditions ameliorated by increasing a blood GLP-1 level. The present invention also relates to the use of a G protein-coupled receptor to screen for GLP-1 secretagogues.

Abstract: A connector body component for a connector assembly in which the connector body component has a plurality of independent body segments secured together to form a single assembly. The connector body segments are held together within a housing member and may include interlocking structures on wall surfaces thereof. Forming the connector body in independent segments allows one body segment to be replaced in the event of damage to the connector body or one conductive element held in the connector body, thus eliminating the need to replace the entire connector body. This saves significant time and expense when repairing or modifying a connector body having a plurality of independent conductors coupled to it.

Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor and to mutated (non-endogenous) versions of the human GPCRs for evidence of constitutive activity.

Abstract: The present invention concerns combination of an amount of a GPR119 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-1 level in a subject over that provided by the amount of the GPR119 agonist or the amount of the DPP-IV inhibitor alone and the use of such a combination for treating or preventing diabetes and conditions related thereto or conditions ameliorated by increasing a blood GLP-1 level. The present invention also relates to the use of a G protein-coupled receptor to screen for GLP-1 secretagogues.